

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to muscle activity (GO:0014850) | 9.77517554 |
| 2 | * visual perception (GO:0007601) | 9.43637996 |
| 3 | * sensory perception of light stimulus (GO:0050953) | 9.32358972 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 8.43026546 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 8.43026546 |
| 6 | camera-type eye development (GO:0043010) | 8.37949224 |
| 7 | regulation of fibrinolysis (GO:0051917) | 8.25786647 |
| 8 | negative regulation of fibrinolysis (GO:0051918) | 8.24020308 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 7.78144282 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.78144282 |
| 11 | cytolysis (GO:0019835) | 7.68273665 |
| 12 | peptidyl-glutamic acid carboxylation (GO:0017187) | 7.52137081 |
| 13 | protein carboxylation (GO:0018214) | 7.52137081 |
| 14 | histone H3-K9 demethylation (GO:0033169) | 7.45404858 |
| 15 | muscle cell cellular homeostasis (GO:0046716) | 7.34556193 |
| 16 | regulation of protein activation cascade (GO:2000257) | 7.22624267 |
| 17 | regulation of complement activation (GO:0030449) | 6.82848766 |
| 18 | eye development (GO:0001654) | 6.77162496 |
| 19 | complement activation, alternative pathway (GO:0006957) | 6.73196631 |
| 20 | cellular response to osmotic stress (GO:0071470) | 6.51863679 |
| 21 | bile acid and bile salt transport (GO:0015721) | 6.44582429 |
| 22 | glyoxylate metabolic process (GO:0046487) | 6.39806109 |
| 23 | blood coagulation, intrinsic pathway (GO:0007597) | 6.36565425 |
| 24 | regulation of protein sumoylation (GO:0033233) | 6.35304152 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.17773418 |
| 26 | fibrinolysis (GO:0042730) | 6.01765335 |
| 27 | negative regulation of sterol transport (GO:0032372) | 5.96538853 |
| 28 | negative regulation of cholesterol transport (GO:0032375) | 5.96538853 |
| 29 | myofibril assembly (GO:0030239) | 5.84786181 |
| 30 | urea metabolic process (GO:0019627) | 5.75397599 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 5.74507981 |
| 32 | drug catabolic process (GO:0042737) | 5.70352953 |
| 33 | regulation of plasminogen activation (GO:0010755) | 5.70282429 |
| 34 | plasma lipoprotein particle remodeling (GO:0034369) | 5.68838655 |
| 35 | protein-lipid complex remodeling (GO:0034368) | 5.68838655 |
| 36 | macromolecular complex remodeling (GO:0034367) | 5.68838655 |
| 37 | exogenous drug catabolic process (GO:0042738) | 5.62946788 |
| 38 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.53066105 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 5.29575409 |
| 40 | cholesterol efflux (GO:0033344) | 5.27586519 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 5.27256592 |
| 42 | aromatic amino acid family catabolic process (GO:0009074) | 5.26871260 |
| 43 | urea cycle (GO:0000050) | 5.26244273 |
| 44 | nitrogen cycle metabolic process (GO:0071941) | 5.20022886 |
| 45 | bile acid biosynthetic process (GO:0006699) | 5.19691993 |
| 46 | ethanol oxidation (GO:0006069) | 5.18196153 |
| 47 | intestinal cholesterol absorption (GO:0030299) | 5.18056190 |
| 48 | sensory organ development (GO:0007423) | 5.16174255 |
| 49 | high-density lipoprotein particle remodeling (GO:0034375) | 5.05589487 |
| 50 | plasma lipoprotein particle assembly (GO:0034377) | 5.04963533 |
| 51 | omega-hydroxylase P450 pathway (GO:0097267) | 5.04873693 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 5.00403800 |
| 53 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.97547958 |
| 54 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.97547958 |
| 55 | tyrosine metabolic process (GO:0006570) | 4.93083147 |
| 56 | cellular glucuronidation (GO:0052695) | 4.75315624 |
| 57 | positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 4.75102275 |
| 58 | low-density lipoprotein particle remodeling (GO:0034374) | 4.71880832 |
| 59 | triglyceride homeostasis (GO:0070328) | 4.70703538 |
| 60 | acylglycerol homeostasis (GO:0055090) | 4.70703538 |
| 61 | bile acid metabolic process (GO:0008206) | 4.69147062 |
| 62 | phospholipid efflux (GO:0033700) | 4.67044461 |
| 63 | negative regulation of blood coagulation (GO:0030195) | 4.66890390 |
| 64 | negative regulation of hemostasis (GO:1900047) | 4.66890390 |
| 65 | plasma lipoprotein particle organization (GO:0071827) | 4.64559241 |
| 66 | reverse cholesterol transport (GO:0043691) | 4.56360725 |
| 67 | negative regulation of protein activation cascade (GO:2000258) | 4.53857886 |
| 68 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 4.52523450 |
| 69 | uronic acid metabolic process (GO:0006063) | 4.49823224 |
| 70 | glucuronate metabolic process (GO:0019585) | 4.49823224 |
| 71 | response to salt stress (GO:0009651) | 4.49502194 |
| 72 | protein activation cascade (GO:0072376) | 4.48942260 |
| 73 | drug metabolic process (GO:0017144) | 4.48880861 |
| 74 | plasma lipoprotein particle clearance (GO:0034381) | 4.48125767 |
| 75 | protein-lipid complex assembly (GO:0065005) | 4.47410842 |
| 76 | glutamate metabolic process (GO:0006536) | 4.40863665 |
| 77 | protein-lipid complex subunit organization (GO:0071825) | 4.35615609 |
| 78 | * sensory perception (GO:0007600) | 4.35020174 |
| 79 | acute-phase response (GO:0006953) | 4.34441318 |
| 80 | glycine metabolic process (GO:0006544) | 4.27548746 |
| 81 | positive regulation of blood coagulation (GO:0030194) | 4.27329645 |
| 82 | positive regulation of hemostasis (GO:1900048) | 4.27329645 |
| 83 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.27273059 |
| 84 | ethanol metabolic process (GO:0006067) | 4.25626253 |
| 85 | negative regulation of coagulation (GO:0050819) | 4.24792081 |
| 86 | sarcomere organization (GO:0045214) | 4.21524795 |
| 87 | proline metabolic process (GO:0006560) | 4.18467644 |
| 88 | negative regulation of wound healing (GO:0061045) | 4.16532985 |
| 89 | oxidative demethylation (GO:0070989) | 4.16481567 |
| 90 | regulation of apoptotic cell clearance (GO:2000425) | 4.14629950 |
| 91 | imidazole-containing compound metabolic process (GO:0052803) | 4.12909954 |
| 92 | phenylpropanoid metabolic process (GO:0009698) | 4.08955387 |
| 93 | regulation of humoral immune response (GO:0002920) | 4.08331083 |
| 94 | negative regulation of lipase activity (GO:0060192) | 4.07649031 |
| 95 | negative regulation of complement activation (GO:0045916) | 4.07591755 |
| 96 | complement activation, classical pathway (GO:0006958) | 4.04455955 |
| 97 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.01576179 |
| 98 | lens development in camera-type eye (GO:0002088) | 35.6349038 |
| 99 | positive regulation of coagulation (GO:0050820) | 3.92653788 |
| 100 | amino-acid betaine metabolic process (GO:0006577) | 3.85178645 |
| 101 | complement activation (GO:0006956) | 3.84357449 |
| 102 | arginine metabolic process (GO:0006525) | 3.78765338 |
| 103 | alpha-amino acid catabolic process (GO:1901606) | 3.75828879 |
| 104 | cholesterol homeostasis (GO:0042632) | 3.71488696 |
| 105 | serine family amino acid metabolic process (GO:0009069) | 3.69003673 |
| 106 | regulation of myoblast differentiation (GO:0045661) | 3.66988619 |
| 107 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.66562407 |
| 108 | sterol homeostasis (GO:0055092) | 3.65961347 |
| 109 | alkaloid metabolic process (GO:0009820) | 3.63455089 |
| 110 | response to mercury ion (GO:0046689) | 3.60384430 |
| 111 | lipoprotein metabolic process (GO:0042157) | 3.54333592 |
| 112 | S-adenosylmethionine metabolic process (GO:0046500) | 3.50031687 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 3.47402890 |
| 114 | protein homotrimerization (GO:0070207) | 3.43557790 |
| 115 | drug transmembrane transport (GO:0006855) | 3.42191131 |
| 116 | flavonoid metabolic process (GO:0009812) | 3.42038302 |
| 117 | lung epithelium development (GO:0060428) | 3.41102888 |
| 118 | regulation of Rac protein signal transduction (GO:0035020) | 3.38691036 |
| 119 | aromatic amino acid family metabolic process (GO:0009072) | 3.37813400 |
| 120 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.37772445 |
| 121 | acute inflammatory response (GO:0002526) | 3.36208713 |
| 122 | cysteine metabolic process (GO:0006534) | 3.35728311 |
| 123 | regulation of lipoprotein particle clearance (GO:0010984) | 3.33696888 |
| 124 | water transport (GO:0006833) | 3.25673030 |
| 125 | regulation of platelet aggregation (GO:0090330) | 3.16057568 |
| 126 | lens fiber cell development (GO:0070307) | 25.3369549 |
| 127 | lens fiber cell differentiation (GO:0070306) | 20.2319624 |
| 128 | positive regulation of wound healing (GO:0090303) | 2.99755337 |
| 129 | positive regulation of calcium ion transport into cytosol (GO:0010524) | 2.97095391 |
| 130 | regulation of skeletal muscle fiber development (GO:0048742) | 2.85973576 |
| 131 | fluid transport (GO:0042044) | 2.80328187 |
| 132 | intermediate filament cytoskeleton organization (GO:0045104) | 2.79262325 |
| 133 | cellular response to calcium ion (GO:0071277) | 2.74991576 |
| 134 | mating behavior (GO:0007617) | 2.68972643 |
| 135 | histone lysine demethylation (GO:0070076) | 2.68915397 |
| 136 | intermediate filament-based process (GO:0045103) | 2.68215490 |
| 137 | dopaminergic neuron differentiation (GO:0071542) | 2.60603903 |
| 138 | cerebellar granule cell differentiation (GO:0021707) | 2.56312744 |
| 139 | response to activity (GO:0014823) | 2.53302548 |
| 140 | rhodopsin mediated signaling pathway (GO:0016056) | 2.52292764 |
| 141 | histone demethylation (GO:0016577) | 2.51055210 |
| 142 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.48995591 |
| 143 | activation of JUN kinase activity (GO:0007257) | 2.44079552 |
| 144 | respiratory tube development (GO:0030323) | 2.39406719 |
| 145 | skeletal muscle organ development (GO:0060538) | 2.35694055 |
| 146 | negative regulation of platelet activation (GO:0010544) | 2.35258817 |
| 147 | epithelial cell development (GO:0002064) | 2.34838990 |
| 148 | negative regulation of cell size (GO:0045792) | 2.32579148 |
| 149 | lung-associated mesenchyme development (GO:0060484) | 2.28451446 |
| 150 | actomyosin structure organization (GO:0031032) | 2.27585383 |
| 151 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.24801146 |
| 152 | regulation of release of sequestered calcium ion into cytosol (GO:0051279) | 2.23073360 |
| 153 | protein demethylation (GO:0006482) | 2.22660733 |
| 154 | protein dealkylation (GO:0008214) | 2.22660733 |
| 155 | collecting duct development (GO:0072044) | 2.16418158 |
| 156 | negative regulation of hormone metabolic process (GO:0032351) | 2.16169146 |
| 157 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.16169146 |
| 158 | response to osmotic stress (GO:0006970) | 2.12526733 |
| 159 | positive regulation of dendritic spine development (GO:0060999) | 2.12033103 |
| 160 | regulation of myotube differentiation (GO:0010830) | 2.11583584 |
| 161 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.11226735 |
| 162 | cell-cell junction assembly (GO:0007043) | 2.08379089 |
| 163 | cellular response to prostaglandin stimulus (GO:0071379) | 2.07794329 |
| 164 | neuronal stem cell maintenance (GO:0097150) | 2.05381553 |
| 165 | diaphragm development (GO:0060539) | 2.05224597 |
| 166 | positive regulation of dendrite morphogenesis (GO:0050775) | 2.05129108 |
| 167 | basement membrane organization (GO:0071711) | 2.04441599 |
| 168 | dorsal/ventral axis specification (GO:0009950) | 2.03715059 |
| 169 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.01666181 |
| 170 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.00203535 |
| 171 | lens morphogenesis in camera-type eye (GO:0002089) | 10.3404859 |
| 172 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 1.99904714 |
| 173 | protein localization to cell surface (GO:0034394) | 1.95659832 |
| 174 | apoptotic process involved in development (GO:1902742) | 1.93636397 |
| 175 | metanephric nephron tubule development (GO:0072234) | 1.91440536 |
| 176 | metanephric tubule development (GO:0072170) | 1.91440536 |
| 177 | photoreceptor cell development (GO:0042461) | 1.88898574 |
| 178 | apoptotic process involved in morphogenesis (GO:0060561) | 1.88749686 |
| 179 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 1.88001785 |
| 180 | synaptic vesicle maturation (GO:0016188) | 1.87449275 |
| 181 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 1.86354133 |
| 182 | carnitine shuttle (GO:0006853) | 1.85425520 |
| 183 | glutamate secretion (GO:0014047) | 1.84301309 |
| 184 | regulation of dendritic spine morphogenesis (GO:0061001) | 1.81345431 |
| 185 | positive regulation of developmental growth (GO:0048639) | 1.81191382 |
| 186 | regulation of bile acid biosynthetic process (GO:0070857) | 1.78331245 |
| 187 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 1.78044386 |
| 188 | protein trimerization (GO:0070206) | 1.76975662 |
| 189 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 1.76906925 |
| 190 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 1.75598077 |
| 191 | metanephric nephron epithelium development (GO:0072243) | 1.73174401 |
| 192 | cell maturation (GO:0048469) | 1.71671302 |
| 193 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 1.70029899 |
| 194 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 1.69369245 |
| 195 | negative regulation of JUN kinase activity (GO:0043508) | 1.68761809 |
| 196 | retinal rod cell development (GO:0046548) | 1.67810110 |
| 197 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 1.67273108 |
| 198 | bone trabecula formation (GO:0060346) | 1.65326806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 9.74230059 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.01518536 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.90602958 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.67776852 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.57451226 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 5.31374694 |
| 7 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 4.81799190 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.53850606 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.30074268 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.89299156 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.75009124 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.58143816 |
| 13 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.35461019 |
| 14 | EGR1_19032775_ChIP-ChIP_M12_Human | 2.97640117 |
| 15 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.90336712 |
| 16 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.80141792 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.65960044 |
| 18 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.60177930 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.54050167 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.23203173 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.15583094 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.09500440 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.09500440 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.06936070 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.00738508 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.97370686 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.94246060 |
| 28 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.88435671 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.81417225 |
| 30 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.75507556 |
| 31 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.73691423 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66423586 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.65754939 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.65068329 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61519847 |
| 36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.60065349 |
| 37 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59745007 |
| 38 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.58790593 |
| 39 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.58453403 |
| 40 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.56996681 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55356988 |
| 42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.53478596 |
| 43 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.50418002 |
| 44 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47824622 |
| 45 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.44725412 |
| 46 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.43470157 |
| 47 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.42991941 |
| 48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.41035691 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40614854 |
| 50 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.37961008 |
| 51 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36658758 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35857421 |
| 53 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34671046 |
| 54 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.34437663 |
| 55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.34080844 |
| 56 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.34039369 |
| 57 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.33186362 |
| 58 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31851809 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31657725 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.29282594 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27652635 |
| 62 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27515368 |
| 63 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.27272773 |
| 64 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.26798846 |
| 65 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.24223879 |
| 66 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.23220998 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22269507 |
| 68 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.19689974 |
| 69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19091844 |
| 70 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.18425731 |
| 71 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.17682810 |
| 72 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.16483334 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16312087 |
| 74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13924324 |
| 75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12963561 |
| 76 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12914067 |
| 77 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.12467113 |
| 78 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.11111322 |
| 79 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10741364 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10709162 |
| 81 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.10175126 |
| 82 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09871996 |
| 83 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09237634 |
| 84 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.09065899 |
| 85 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06888983 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05268325 |
| 87 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.04385422 |
| 88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03931023 |
| 89 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03335973 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02989686 |
| 91 | VDR_22108803_ChIP-Seq_LS180_Human | 1.01513492 |
| 92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01095308 |
| 93 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00205222 |
| 94 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.99800070 |
| 95 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99318827 |
| 96 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.99193367 |
| 97 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98881154 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97858304 |
| 99 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97760593 |
| 100 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97608561 |
| 101 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.97260309 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95847228 |
| 103 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.95179064 |
| 104 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94017810 |
| 105 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.93663772 |
| 106 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93308849 |
| 107 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.93190487 |
| 108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92433447 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92413259 |
| 110 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92291944 |
| 111 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90989457 |
| 112 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89926635 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89705035 |
| 114 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88447632 |
| 115 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.87863902 |
| 116 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.87028729 |
| 117 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.86988423 |
| 118 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86826779 |
| 119 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86322153 |
| 120 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.85460587 |
| 121 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.84509990 |
| 122 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.83271384 |
| 123 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83076980 |
| 124 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82322962 |
| 125 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.81621315 |
| 126 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.81297005 |
| 127 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.80787223 |
| 128 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.80052254 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.79909619 |
| 130 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.79757619 |
| 131 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.78785712 |
| 132 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78284863 |
| 133 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77100006 |
| 134 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.76945557 |
| 135 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76937418 |
| 136 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.76469532 |
| 137 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.76209325 |
| 138 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.75935913 |
| 139 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75840469 |
| 140 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75603140 |
| 141 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.75297085 |
| 142 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.74519976 |
| 143 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.74037801 |
| 144 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73576971 |
| 145 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.73139939 |
| 146 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.72576491 |
| 147 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.71716306 |
| 148 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67878562 |
| 149 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.67773836 |
| 150 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.66587754 |
| 151 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.66210380 |
| 152 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.65603732 |
| 153 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65343709 |
| 154 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64347695 |
| 155 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.63716738 |
| 156 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.63708033 |
| 157 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.62432124 |
| 158 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62182450 |
| 159 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.61537751 |
| 160 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.61222911 |
| 161 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.60686216 |
| 162 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.60530604 |
| 163 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.60041808 |
| 164 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.59645358 |
| 165 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.59114038 |
| 166 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.58288162 |
| 167 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57040483 |
| 168 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56836631 |
| 169 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.56693352 |
| 170 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.55835358 |
| 171 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.55484871 |
| 172 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.54337767 |
| 173 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52581747 |
| 174 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.50999950 |
| 175 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.50679273 |
| 176 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.49414259 |
| 177 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.48957138 |
| 178 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.48306318 |
| 179 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.46894809 |
| 180 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.46775469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005193_abnormal_anterior_eye | 8.70449170 |
| 2 | MP0005365_abnormal_bile_salt | 5.90772948 |
| 3 | MP0005253_abnormal_eye_physiology | 5.77201829 |
| 4 | MP0003195_calcinosis | 5.42316871 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.01654416 |
| 6 | MP0001286_abnormal_eye_development | 3.85235316 |
| 7 | MP0003868_abnormal_feces_composition | 3.79786793 |
| 8 | MP0005197_abnormal_uvea_morphology | 3.75703766 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.74065940 |
| 10 | MP0002092_abnormal_eye_morphology | 3.66692158 |
| 11 | MP0000749_muscle_degeneration | 3.62631742 |
| 12 | MP0005391_vision/eye_phenotype | 3.55639153 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 3.29013177 |
| 14 | MP0010329_abnormal_lipoprotein_level | 3.24268465 |
| 15 | MP0003941_abnormal_skin_development | 3.09370072 |
| 16 | MP0002090_abnormal_vision | 2.81545062 |
| 17 | MP0009697_abnormal_copulation | 2.67189066 |
| 18 | MP0005332_abnormal_amino_acid | 2.21565996 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 2.20248717 |
| 20 | MP0001346_abnormal_lacrimal_gland | 2.19043179 |
| 21 | MP0003122_maternal_imprinting | 2.03066406 |
| 22 | * MP0002697_abnormal_eye_size | 13.1352404 |
| 23 | MP0009840_abnormal_foam_cell | 1.94886317 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 1.93497119 |
| 25 | MP0002638_abnormal_pupillary_reflex | 1.90930865 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.81015638 |
| 27 | MP0000609_abnormal_liver_physiology | 1.80839589 |
| 28 | MP0003011_delayed_dark_adaptation | 1.72202836 |
| 29 | MP0005195_abnormal_posterior_eye | 1.70616263 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.69023025 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.65340337 |
| 32 | MP0002108_abnormal_muscle_morphology | 1.62776231 |
| 33 | MP0005408_hypopigmentation | 1.54542102 |
| 34 | MP0004272_abnormal_basement_membrane | 1.49881012 |
| 35 | MP0005451_abnormal_body_composition | 1.47718458 |
| 36 | MP0002269_muscular_atrophy | 1.46897504 |
| 37 | MP0001764_abnormal_homeostasis | 1.45675036 |
| 38 | MP0000566_synostosis | 1.44568682 |
| 39 | MP0005330_cardiomyopathy | 1.44304005 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.43703189 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.29648721 |
| 42 | MP0002132_abnormal_respiratory_system | 1.17912890 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.16539461 |
| 44 | MP0000598_abnormal_liver_morphology | 1.11406385 |
| 45 | MP0001299_abnormal_eye_distance/ | 1.06082203 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.03992881 |
| 47 | MP0006072_abnormal_retinal_apoptosis | 1.02816301 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.02325594 |
| 49 | MP0001661_extended_life_span | 1.01607976 |
| 50 | MP0002735_abnormal_chemical_nociception | 0.98659180 |
| 51 | MP0000604_amyloidosis | 0.97802434 |
| 52 | MP0009643_abnormal_urine_homeostasis | 0.96594682 |
| 53 | MP0002139_abnormal_hepatobiliary_system | 0.93739810 |
| 54 | MP0003878_abnormal_ear_physiology | 0.92058450 |
| 55 | MP0005377_hearing/vestibular/ear_phenot | 0.92058450 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 0.90475040 |
| 57 | MP0001324_abnormal_eye_pigmentation | 0.89390773 |
| 58 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87273202 |
| 59 | MP0004859_abnormal_synaptic_plasticity | 0.86430554 |
| 60 | MP0002653_abnormal_ependyma_morphology | 0.84437141 |
| 61 | MP0009642_abnormal_blood_homeostasis | 0.83463193 |
| 62 | MP0001340_abnormal_eyelid_morphology | 0.82882634 |
| 63 | MP0005670_abnormal_white_adipose | 0.76675152 |
| 64 | MP0003879_abnormal_hair_cell | 0.75524421 |
| 65 | MP0006292_abnormal_olfactory_placode | 0.75080098 |
| 66 | MP0004087_abnormal_muscle_fiber | 0.73467121 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 0.67342003 |
| 68 | MP0004885_abnormal_endolymph | 0.65588523 |
| 69 | MP0005395_other_phenotype | 0.63801394 |
| 70 | MP0005187_abnormal_penis_morphology | 0.62839363 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.62552503 |
| 72 | MP0005369_muscle_phenotype | 0.62111060 |
| 73 | MP0008469_abnormal_protein_level | 0.61842892 |
| 74 | MP0003252_abnormal_bile_duct | 0.61628935 |
| 75 | MP0005376_homeostasis/metabolism_phenot | 0.61211549 |
| 76 | MP0002971_abnormal_brown_adipose | 0.60296811 |
| 77 | MP0003123_paternal_imprinting | 0.59885672 |
| 78 | MP0000759_abnormal_skeletal_muscle | 0.59744267 |
| 79 | MP0002734_abnormal_mechanical_nocicepti | 0.59525883 |
| 80 | MP0009763_increased_sensitivity_to | 0.58775022 |
| 81 | MP0003186_abnormal_redox_activity | 0.56178770 |
| 82 | MP0003638_abnormal_response/metabolism_ | 0.56129438 |
| 83 | MP0002168_other_aberrant_phenotype | 0.56013213 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 0.55981389 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.55298072 |
| 86 | MP0003635_abnormal_synaptic_transmissio | 0.54576566 |
| 87 | MP0004270_analgesia | 0.54422706 |
| 88 | MP0000049_abnormal_middle_ear | 0.54178670 |
| 89 | MP0005423_abnormal_somatic_nervous | 0.51369750 |
| 90 | MP0000639_abnormal_adrenal_gland | 0.51033587 |
| 91 | MP0002282_abnormal_trachea_morphology | 0.50531885 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 0.50079014 |
| 93 | MP0001915_intracranial_hemorrhage | 0.49808440 |
| 94 | MP0005248_abnormal_Harderian_gland | 0.48757888 |
| 95 | MP0001905_abnormal_dopamine_level | 0.47832857 |
| 96 | MP0001968_abnormal_touch/_nociception | 0.47017038 |
| 97 | MP0008872_abnormal_physiological_respon | 0.46969233 |
| 98 | MP0005084_abnormal_gallbladder_morpholo | 0.46292972 |
| 99 | MP0005409_darkened_coat_color | 0.45939225 |
| 100 | MP0002229_neurodegeneration | 0.45586832 |
| 101 | MP0005257_abnormal_intraocular_pressure | 0.45544017 |
| 102 | MP0002089_abnormal_postnatal_growth/wei | 0.45419460 |
| 103 | MP0003787_abnormal_imprinting | 0.44390557 |
| 104 | MP0000537_abnormal_urethra_morphology | 0.44308586 |
| 105 | MP0009053_abnormal_anal_canal | 0.43910358 |
| 106 | MP0003690_abnormal_glial_cell | 0.41759831 |
| 107 | MP0000747_muscle_weakness | 0.40985098 |
| 108 | MP0001879_abnormal_lymphatic_vessel | 0.40685604 |
| 109 | MP0001756_abnormal_urination | 0.40066894 |
| 110 | MP0001502_abnormal_circadian_rhythm | 0.39927416 |
| 111 | MP0002736_abnormal_nociception_after | 0.39794436 |
| 112 | MP0003315_abnormal_perineum_morphology | 0.39419675 |
| 113 | MP0002882_abnormal_neuron_morphology | 0.39287181 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.38687106 |
| 115 | MP0005164_abnormal_response_to | 0.37516310 |
| 116 | MP0003329_amyloid_beta_deposits | 0.37087745 |
| 117 | MP0002063_abnormal_learning/memory/cond | 0.36932847 |
| 118 | MP0005448_abnormal_energy_balance | 0.36911615 |
| 119 | MP0006054_spinal_hemorrhage | 0.36856130 |
| 120 | MP0003567_abnormal_fetal_cardiomyocyte | 0.36636849 |
| 121 | MP0000751_myopathy | 0.36100778 |
| 122 | MP0004883_abnormal_blood_vessel | 0.35938914 |
| 123 | MP0000428_abnormal_craniofacial_morphol | 0.35365705 |
| 124 | MP0003953_abnormal_hormone_level | 0.35334599 |
| 125 | MP0005360_urolithiasis | 0.34779821 |
| 126 | MP0004233_abnormal_muscle_weight | 0.33952434 |
| 127 | MP0005085_abnormal_gallbladder_physiolo | 0.33901939 |
| 128 | MP0004811_abnormal_neuron_physiology | 0.33843005 |
| 129 | MP0004782_abnormal_surfactant_physiolog | 0.33436559 |
| 130 | MP0001270_distended_abdomen | 0.33089226 |
| 131 | MP0002064_seizures | 0.32753474 |
| 132 | MP0000249_abnormal_blood_vessel | 0.32729387 |
| 133 | MP0003115_abnormal_respiratory_system | 0.32488744 |
| 134 | MP0003121_genomic_imprinting | 0.31871239 |
| 135 | MP0003942_abnormal_urinary_system | 0.31684114 |
| 136 | MP0003566_abnormal_cell_adhesion | 0.31346768 |
| 137 | MP0001943_abnormal_respiration | 0.31101050 |
| 138 | MP0002938_white_spotting | 0.30643758 |
| 139 | MP0000465_gastrointestinal_hemorrhage | 0.30298284 |
| 140 | MP0002152_abnormal_brain_morphology | 0.30219520 |
| 141 | MP0000920_abnormal_myelination | 0.30214063 |
| 142 | MP0005334_abnormal_fat_pad | 0.30140618 |
| 143 | MP0003632_abnormal_nervous_system | 0.30111578 |
| 144 | MP0002249_abnormal_larynx_morphology | 0.29895125 |
| 145 | MP0003718_maternal_effect | 0.29880500 |
| 146 | MP0000955_abnormal_spinal_cord | 0.29479188 |
| 147 | MP0003656_abnormal_erythrocyte_physiolo | 0.29286438 |
| 148 | MP0002136_abnormal_kidney_physiology | 0.28475234 |
| 149 | MP0003183_abnormal_peptide_metabolism | 0.27927062 |
| 150 | MP0005535_abnormal_body_temperature | 0.27860659 |
| 151 | MP0009115_abnormal_fat_cell | 0.27703732 |
| 152 | MP0009764_decreased_sensitivity_to | 0.26829505 |
| 153 | MP0008874_decreased_physiological_sensi | 0.26740580 |
| 154 | MP0002925_abnormal_cardiovascular_devel | 0.26666298 |
| 155 | MP0003075_altered_response_to | 0.26542993 |
| 156 | MP0002752_abnormal_somatic_nervous | 0.26406769 |
| 157 | MP0004084_abnormal_cardiac_muscle | 0.26400874 |
| 158 | MP0002177_abnormal_outer_ear | 0.26165052 |
| 159 | MP0009672_abnormal_birth_weight | 0.26157787 |
| 160 | MP0001958_emphysema | 0.25155638 |
| 161 | MP0010234_abnormal_vibrissa_follicle | 0.24860171 |
| 162 | MP0004134_abnormal_chest_morphology | 0.24729258 |
| 163 | MP0005623_abnormal_meninges_morphology | 0.24250042 |
| 164 | MP0002733_abnormal_thermal_nociception | 0.24112497 |
| 165 | MP0004197_abnormal_fetal_growth/weight/ | 0.23877803 |
| 166 | MP0001486_abnormal_startle_reflex | 0.23296426 |
| 167 | MP0002272_abnormal_nervous_system | 0.23203850 |
| 168 | MP0001614_abnormal_blood_vessel | 0.22715562 |
| 169 | MP0002184_abnormal_innervation | 0.22443819 |
| 170 | MP0009250_abnormal_appendicular_skeleto | 0.21356360 |
| 171 | MP0004858_abnormal_nervous_system | 0.21351636 |
| 172 | MP0003634_abnormal_glial_cell | 0.20705554 |
| 173 | MP0000778_abnormal_nervous_system | 0.20648181 |
| 174 | MP0001784_abnormal_fluid_regulation | 0.20272718 |
| 175 | MP0003959_abnormal_lean_body | 0.19238345 |
| 176 | MP0002909_abnormal_adrenal_gland | 0.19006892 |
| 177 | MP0004145_abnormal_muscle_electrophysio | 0.18225460 |
| 178 | MP0002066_abnormal_motor_capabilities/c | 0.17894443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 9.11288995 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.90232973 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.09494711 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 8.07696726 |
| 5 | Congenital cataract (HP:0000519) | 7.92601026 |
| 6 | Complement deficiency (HP:0004431) | 7.03750730 |
| 7 | Joint hemorrhage (HP:0005261) | 6.61783212 |
| 8 | * Corneal dystrophy (HP:0001131) | 6.38837916 |
| 9 | Anterior segment dysgenesis (HP:0007700) | 5.87162716 |
| 10 | Abnormality of complement system (HP:0005339) | 5.44337413 |
| 11 | Xanthomatosis (HP:0000991) | 5.15866668 |
| 12 | Glomerulonephritis (HP:0000099) | 5.10341775 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 5.10103146 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 5.00190750 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 4.86939473 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.79976014 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.76595011 |
| 18 | Conjugated hyperbilirubinemia (HP:0002908) | 4.55408836 |
| 19 | Polar cataract (HP:0010696) | 4.54720314 |
| 20 | Clumsiness (HP:0002312) | 3.91484350 |
| 21 | * Amblyopia (HP:0000646) | 3.90768213 |
| 22 | Hypercholesterolemia (HP:0003124) | 3.90390874 |
| 23 | Hemorrhage of the eye (HP:0011885) | 3.85855902 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.80957282 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.77798061 |
| 26 | Menorrhagia (HP:0000132) | 3.55369339 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.47593202 |
| 28 | Vascular calcification (HP:0004934) | 3.31785218 |
| 29 | Spontaneous abortion (HP:0005268) | 3.31640383 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.27780178 |
| 31 | Fat malabsorption (HP:0002630) | 3.27229948 |
| 32 | * Microcornea (HP:0000482) | 3.26329180 |
| 33 | Epidermoid cyst (HP:0200040) | 3.24612529 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.18512411 |
| 35 | Nephritis (HP:0000123) | 3.07341858 |
| 36 | Cholecystitis (HP:0001082) | 3.00731851 |
| 37 | Abnormal gallbladder physiology (HP:0012438) | 3.00731851 |
| 38 | Nuclear cataract (HP:0100018) | 27.4619707 |
| 39 | Zonular cataract (HP:0010920) | 24.8690202 |
| 40 | Purpura (HP:0000979) | 2.94819122 |
| 41 | Cardiovascular calcification (HP:0011915) | 2.92489692 |
| 42 | Mitral stenosis (HP:0001718) | 2.92482773 |
| 43 | Generalized aminoaciduria (HP:0002909) | 2.91194346 |
| 44 | Hyperglycinemia (HP:0002154) | 2.90108422 |
| 45 | Arthropathy (HP:0003040) | 2.83033853 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76890007 |
| 47 | Eosinophilia (HP:0001880) | 2.74976082 |
| 48 | Hyperammonemia (HP:0001987) | 2.67952262 |
| 49 | Osteomalacia (HP:0002749) | 2.66515817 |
| 50 | Gingival bleeding (HP:0000225) | 2.65816945 |
| 51 | Rickets (HP:0002748) | 2.65482401 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.63119007 |
| 53 | Abnormality of methionine metabolism (HP:0010901) | 2.58140754 |
| 54 | * Iris coloboma (HP:0000612) | 2.55118116 |
| 55 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.54596731 |
| 56 | Abnormality of glycine metabolism (HP:0010895) | 2.54596731 |
| 57 | Abnormality of the anterior chamber (HP:0000593) | 2.47628208 |
| 58 | Abnormality of the Achilles tendon (HP:0005109) | 2.44265683 |
| 59 | Reduced antithrombin III activity (HP:0001976) | 2.41658038 |
| 60 | Hypophosphatemic rickets (HP:0004912) | 2.40853907 |
| 61 | Acanthocytosis (HP:0001927) | 2.40822626 |
| 62 | Sclerocornea (HP:0000647) | 2.38322497 |
| 63 | Posterior subcapsular cataract (HP:0007787) | 2.37792248 |
| 64 | Myocardial infarction (HP:0001658) | 2.37659576 |
| 65 | Hyperglycinuria (HP:0003108) | 2.34237840 |
| 66 | * Opacification of the corneal stroma (HP:0007759) | 2.29821019 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.28374907 |
| 68 | Thrombophlebitis (HP:0004418) | 2.24411018 |
| 69 | Pulmonary embolism (HP:0002204) | 2.21902981 |
| 70 | Proximal tubulopathy (HP:0000114) | 2.21129013 |
| 71 | Congenital primary aphakia (HP:0007707) | 2.18447713 |
| 72 | Granulocytopenia (HP:0001913) | 2.17627992 |
| 73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.15649324 |
| 74 | Cholelithiasis (HP:0001081) | 2.13372707 |
| 75 | Abnormality of serum amino acid levels (HP:0003112) | 2.10542636 |
| 76 | Abnormality of carpal bone ossification (HP:0006257) | 2.10055938 |
| 77 | Proximal amyotrophy (HP:0007126) | 2.08482243 |
| 78 | Scapular winging (HP:0003691) | 2.07987634 |
| 79 | Steatorrhea (HP:0002570) | 2.06596891 |
| 80 | Abnormality of glycolysis (HP:0004366) | 2.03343221 |
| 81 | Deep venous thrombosis (HP:0002625) | 11.8425110 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 1.98886244 |
| 83 | Increased serum pyruvate (HP:0003542) | 1.97922233 |
| 84 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.97910190 |
| 85 | Abnormal tarsal ossification (HP:0008369) | 1.96976436 |
| 86 | Poikilocytosis (HP:0004447) | 1.92857051 |
| 87 | Bifid scrotum (HP:0000048) | 1.89732375 |
| 88 | Abnormality of eosinophils (HP:0001879) | 1.87630740 |
| 89 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.84077200 |
| 90 | Abnormality of proline metabolism (HP:0010907) | 1.83307422 |
| 91 | Hydroxyprolinuria (HP:0003080) | 1.83307422 |
| 92 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.83081408 |
| 93 | Hyperbilirubinemia (HP:0002904) | 1.82552145 |
| 94 | Vaginal fistula (HP:0004320) | 1.82044529 |
| 95 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.81072386 |
| 96 | Facial shape deformation (HP:0011334) | 1.71759177 |
| 97 | Potter facies (HP:0002009) | 1.71759177 |
| 98 | Hyperphosphaturia (HP:0003109) | 1.71329218 |
| 99 | Broad alveolar ridges (HP:0000187) | 1.71292218 |
| 100 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.71177640 |
| 101 | Small epiphyses (HP:0010585) | 1.70711541 |
| 102 | Elevated alkaline phosphatase (HP:0003155) | 1.70520281 |
| 103 | Hypoglycemic coma (HP:0001325) | 1.69214577 |
| 104 | Gangrene (HP:0100758) | 1.68670322 |
| 105 | Abnormality of the lumbar spine (HP:0100712) | 1.66895889 |
| 106 | Gout (HP:0001997) | 1.65467560 |
| 107 | Glycosuria (HP:0003076) | 1.64916602 |
| 108 | Abnormality of urine glucose concentration (HP:0011016) | 1.64916602 |
| 109 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.64786003 |
| 110 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.64088432 |
| 111 | Reticulocytosis (HP:0001923) | 1.63782157 |
| 112 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.62598612 |
| 113 | Metabolic acidosis (HP:0001942) | 1.61421478 |
| 114 | Irritability (HP:0000737) | 1.60194409 |
| 115 | Neonatal respiratory distress (HP:0002643) | 1.57817947 |
| 116 | Abnormality of purine metabolism (HP:0004352) | 1.55175047 |
| 117 | Increased serum ferritin (HP:0003281) | 1.53873463 |
| 118 | Abnormal ossification of hand bones (HP:0005921) | 1.53203979 |
| 119 | Back pain (HP:0003418) | 1.53067151 |
| 120 | Abnormal hand bone ossification (HP:0010660) | 1.52263386 |
| 121 | Flat acetabular roof (HP:0003180) | 1.51769557 |
| 122 | Fair hair (HP:0002286) | 1.51249950 |
| 123 | Fetal akinesia sequence (HP:0001989) | 1.50690833 |
| 124 | Severe visual impairment (HP:0001141) | 1.47376461 |
| 125 | Popliteal pterygium (HP:0009756) | 1.43064510 |
| 126 | Long clavicles (HP:0000890) | 1.42945335 |
| 127 | Congenital stationary night blindness (HP:0007642) | 1.38560597 |
| 128 | Aplasia of the musculature (HP:0100854) | 1.36552260 |
| 129 | Subcapsular cataract (HP:0000523) | 1.30177855 |
| 130 | Hypoplastic nipples (HP:0002557) | 1.29913307 |
| 131 | Akinesia (HP:0002304) | 1.28515603 |
| 132 | Abnormality of placental membranes (HP:0011409) | 1.27738707 |
| 133 | Amniotic constriction ring (HP:0009775) | 1.27738707 |
| 134 | Difficulty walking (HP:0002355) | 1.26004148 |
| 135 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.23776747 |
| 136 | Leukocytosis (HP:0001974) | 1.21147713 |
| 137 | Central scotoma (HP:0000603) | 1.12384372 |
| 138 | Chorioretinal atrophy (HP:0000533) | 1.11450596 |
| 139 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.09392890 |
| 140 | Rib fusion (HP:0000902) | 1.06733310 |
| 141 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.03725851 |
| 142 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.03079368 |
| 143 | Fused cervical vertebrae (HP:0002949) | 1.01649680 |
| 144 | Vertebral clefting (HP:0008428) | 0.97033568 |
| 145 | Bony spicule pigmentary retinopathy (HP:0007737) | 0.95897547 |
| 146 | Scotoma (HP:0000575) | 0.94954254 |
| 147 | Abnormality of the labia majora (HP:0012881) | 0.93739196 |
| 148 | Chorioretinal coloboma (HP:0000567) | 0.88639439 |
| 149 | Pendular nystagmus (HP:0012043) | 0.80284454 |
| 150 | Exostoses (HP:0100777) | 0.79286487 |
| 151 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 0.76619988 |
| 152 | Abolished electroretinogram (ERG) (HP:0000550) | 0.73626438 |
| 153 | Pigmentary retinal degeneration (HP:0001146) | 0.72517973 |
| 154 | Lymphangioma (HP:0100764) | 0.72156842 |
| 155 | Decreased central vision (HP:0007663) | 0.72080472 |
| 156 | Camptodactyly of toe (HP:0001836) | 0.71045162 |
| 157 | Neoplasm of the heart (HP:0100544) | 0.71028163 |
| 158 | Pterygium (HP:0001059) | 0.70953780 |
| 159 | Abnormal number of incisors (HP:0011064) | 0.69904568 |
| 160 | Ependymoma (HP:0002888) | 0.68502715 |
| 161 | Photophobia (HP:0000613) | 0.68288859 |
| 162 | Malignant hyperthermia (HP:0002047) | 0.65817532 |
| 163 | Thin ribs (HP:0000883) | 0.64795829 |
| 164 | Hypoplastic heart (HP:0001961) | 0.61475679 |
| 165 | Muscle fiber splitting (HP:0003555) | 0.58312377 |
| 166 | Abnormality of macular pigmentation (HP:0008002) | 0.57879037 |
| 167 | Hyporeflexia of lower limbs (HP:0002600) | 0.57077745 |
| 168 | Macular degeneration (HP:0000608) | 0.56176665 |
| 169 | Aplasia/Hypoplasia of the nipples (HP:0006709) | 0.55786953 |
| 170 | Cystic hygroma (HP:0000476) | 0.55649670 |
| 171 | Pointed chin (HP:0000307) | 0.54627148 |
| 172 | Abnormality of the astrocytes (HP:0100707) | 0.53983075 |
| 173 | Astrocytoma (HP:0009592) | 0.53983075 |
| 174 | Diminished movement (HP:0002374) | 0.53968943 |
| 175 | Dislocated radial head (HP:0003083) | 0.53204402 |
| 176 | Hepatoblastoma (HP:0002884) | 0.52129368 |
| 177 | Hemiplegia (HP:0002301) | 0.52014846 |
| 178 | Increased corneal curvature (HP:0100692) | 0.51435864 |
| 179 | Keratoconus (HP:0000563) | 0.51435864 |
| 180 | Abnormality of the humeroradial joint (HP:0100744) | 0.50445395 |
| 181 | Split foot (HP:0001839) | 0.50144477 |
| 182 | * Autosomal dominant inheritance (HP:0000006) | 0.50137672 |
| 183 | Attenuation of retinal blood vessels (HP:0007843) | 0.49450801 |
| 184 | Hamartoma of the eye (HP:0010568) | 0.48933414 |
| 185 | Abnormality of the radial head (HP:0003995) | 0.48867175 |
| 186 | Visceral angiomatosis (HP:0100761) | 0.48505085 |
| 187 | Enlarged kidneys (HP:0000105) | 0.48256705 |
| 188 | Flexion contracture of toe (HP:0005830) | 0.47603896 |
| 189 | Joint contractures involving the joints of the feet (HP:0100492) | 0.47603896 |
| 190 | Broad nasal tip (HP:0000455) | 0.46349801 |
| 191 | Cone-rod dystrophy (HP:0000548) | 0.45773308 |
| 192 | Annular pancreas (HP:0001734) | 0.45735081 |
| 193 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 0.44755391 |
| 194 | Buphthalmos (HP:0000557) | 0.44391325 |
| 195 | Skin nodule (HP:0200036) | 0.44262433 |
| 196 | Type II diabetes mellitus (HP:0005978) | 0.44203990 |
| 197 | Hemangiomatosis (HP:0007461) | 0.44021563 |
| 198 | Hypoplastic pelvis (HP:0008839) | 0.43923899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP2K6 | 8.15496114 |
| 2 | FGFR4 | 7.60061642 |
| 3 | BLK | 4.67266169 |
| 4 | FGFR3 | 4.35977111 |
| 5 | ERN1 | 3.65835510 |
| 6 | WNK4 | 3.10157965 |
| 7 | STK39 | 3.09318301 |
| 8 | NTRK1 | 2.72295455 |
| 9 | BCKDK | 2.69883507 |
| 10 | PIK3CA | 2.59295898 |
| 11 | FLT3 | 2.57483402 |
| 12 | MST4 | 2.51929756 |
| 13 | SIK1 | 2.48732791 |
| 14 | PKN2 | 2.32076190 |
| 15 | * SGK1 | 2.25176458 |
| 16 | TRIB3 | 2.10126388 |
| 17 | MAP3K10 | 2.09160060 |
| 18 | TYRO3 | 1.94231463 |
| 19 | DYRK1B | 1.92226777 |
| 20 | PNCK | 1.90633546 |
| 21 | IGF1R | 1.73484853 |
| 22 | PDGFRA | 1.73209748 |
| 23 | MET | 1.66472332 |
| 24 | LRRK2 | 1.57092748 |
| 25 | PRKAA2 | 1.55899248 |
| 26 | INSR | 1.51625921 |
| 27 | ERBB2 | 1.51222020 |
| 28 | ICK | 1.45859999 |
| 29 | MAPK11 | 1.39649916 |
| 30 | DDR2 | 1.38668862 |
| 31 | GRK1 | 1.37072589 |
| 32 | EPHB2 | 1.36824250 |
| 33 | WNK1 | 1.36281271 |
| 34 | * PRKG1 | 1.35197485 |
| 35 | * PRKCB | 1.30040904 |
| 36 | PRKACB | 1.25803244 |
| 37 | PAK6 | 1.24295941 |
| 38 | SCYL2 | 1.23924979 |
| 39 | RET | 1.23920185 |
| 40 | AKT3 | 1.23336960 |
| 41 | CAMK1G | 1.19442164 |
| 42 | PDPK1 | 1.19250492 |
| 43 | PTK6 | 1.14600746 |
| 44 | SMG1 | 1.13575629 |
| 45 | TESK2 | 1.13337913 |
| 46 | CDK6 | 1.11937111 |
| 47 | ZAP70 | 1.07021203 |
| 48 | IRAK3 | 1.05235867 |
| 49 | PKN1 | 1.05060416 |
| 50 | EPHA4 | 1.01996525 |
| 51 | TGFBR2 | 1.01521620 |
| 52 | SIK2 | 1.00879996 |
| 53 | CAMKK1 | 0.98631686 |
| 54 | PAK4 | 0.97427888 |
| 55 | EPHA3 | 0.94097435 |
| 56 | STK10 | 0.92662309 |
| 57 | WNK3 | 0.91797218 |
| 58 | ROCK2 | 0.89420372 |
| 59 | CDK7 | 0.85647522 |
| 60 | PTK2 | 0.85412629 |
| 61 | PRKACG | 0.84607020 |
| 62 | MAP2K4 | 0.83692834 |
| 63 | TYK2 | 0.83466693 |
| 64 | PRKCG | 0.83391506 |
| 65 | PRKCQ | 0.81337177 |
| 66 | EEF2K | 0.79190956 |
| 67 | PDK1 | 0.77798398 |
| 68 | * RPS6KA3 | 0.76951105 |
| 69 | PAK3 | 0.76575399 |
| 70 | LATS1 | 0.75179172 |
| 71 | PHKG2 | 0.74662278 |
| 72 | PHKG1 | 0.74662278 |
| 73 | PIM2 | 0.73825923 |
| 74 | PRKAA1 | 0.73428571 |
| 75 | SGK3 | 0.73154433 |
| 76 | SGK223 | 0.71622134 |
| 77 | SGK494 | 0.71622134 |
| 78 | MINK1 | 0.69265652 |
| 79 | SGK2 | 0.68318907 |
| 80 | MAP3K2 | 0.67361241 |
| 81 | EIF2AK1 | 0.64333015 |
| 82 | ILK | 0.64061172 |
| 83 | ROCK1 | 0.63490111 |
| 84 | RPS6KB1 | 0.61977039 |
| 85 | MAP3K5 | 0.61889558 |
| 86 | PRKCH | 0.61759879 |
| 87 | MAP2K3 | 0.60746551 |
| 88 | HIPK2 | 0.59936361 |
| 89 | MAPKAPK3 | 0.59334455 |
| 90 | CSF1R | 0.59262317 |
| 91 | RPS6KA2 | 0.59144031 |
| 92 | CSNK1D | 0.58195017 |
| 93 | FGFR1 | 0.57521339 |
| 94 | FGR | 0.57386322 |
| 95 | IRAK2 | 0.56938965 |
| 96 | BCR | 0.56496338 |
| 97 | ALK | 0.55138960 |
| 98 | CDK5 | 0.55035888 |
| 99 | CDC42BPA | 0.53170143 |
| 100 | CDK12 | 0.52851529 |
| 101 | MTOR | 0.52334931 |
| 102 | LATS2 | 0.51986954 |
| 103 | MAPKAPK5 | 0.49258081 |
| 104 | NTRK3 | 0.48508988 |
| 105 | MAP3K11 | 0.47698146 |
| 106 | UHMK1 | 0.46671872 |
| 107 | CSNK2A2 | 0.46298620 |
| 108 | ADRBK1 | 0.45772423 |
| 109 | MATK | 0.45320848 |
| 110 | MARK1 | 0.45210113 |
| 111 | CDK8 | 0.45124033 |
| 112 | EPHA2 | 0.44788999 |
| 113 | MAP3K3 | 0.43061657 |
| 114 | PDK2 | 0.41965443 |
| 115 | PRKACA | 0.40995675 |
| 116 | CDK4 | 0.40565023 |
| 117 | EGFR | 0.40298148 |
| 118 | RIPK1 | 0.40015622 |
| 119 | CSNK1E | 0.39263439 |
| 120 | GSK3A | 0.38335275 |
| 121 | CAMK1D | 0.38156251 |
| 122 | MAP3K9 | 0.37495127 |
| 123 | BRD4 | 0.36987579 |
| 124 | PDGFRB | 0.36885267 |
| 125 | MARK2 | 0.36742054 |
| 126 | PAK2 | 0.35384403 |
| 127 | PRKCA | 0.35092408 |
| 128 | BRSK1 | 0.34447571 |
| 129 | RPS6KA1 | 0.34444339 |
| 130 | CSNK2A1 | 0.34385409 |
| 131 | PLK2 | 0.34126856 |
| 132 | MAP3K1 | 0.33701116 |
| 133 | PTK2B | 0.33404242 |
| 134 | BMX | 0.32458263 |
| 135 | MAPK3 | 0.31150947 |
| 136 | FER | 0.31028334 |
| 137 | CSNK1A1L | 0.30543979 |
| 138 | KSR1 | 0.30447446 |
| 139 | NEK1 | 0.30086113 |
| 140 | FYN | 0.29828347 |
| 141 | * MAPK10 | 0.28661497 |
| 142 | MAP3K7 | 0.28515289 |
| 143 | TAOK3 | 0.28000339 |
| 144 | STK38 | 0.27990165 |
| 145 | CDK14 | 0.27877611 |
| 146 | MAP3K4 | 0.26204998 |
| 147 | NEK9 | 0.24866790 |
| 148 | STK16 | 0.24423306 |
| 149 | NLK | 0.24121008 |
| 150 | PRKD3 | 0.24104158 |
| 151 | CDK9 | 0.24082476 |
| 152 | PRKCZ | 0.24048149 |
| 153 | FGFR2 | 0.23565554 |
| 154 | SRC | 0.23477149 |
| 155 | CDK15 | 0.23313795 |
| 156 | STK11 | 0.22923317 |
| 157 | TTN | 0.22852873 |
| 158 | FES | 0.22068829 |
| 159 | AKT2 | 0.22068699 |
| 160 | KSR2 | 0.21751684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 6.09300298 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.28370430 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.08344084 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.89958676 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.79664391 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 2.77711718 |
| 7 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.71403093 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.60118138 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.51865886 |
| 10 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.47389496 |
| 11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.38973319 |
| 12 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.23267183 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.09038295 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.94663374 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94574830 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.84316717 |
| 17 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.83102221 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.79354469 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.75191605 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.72959627 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.72576613 |
| 22 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.70657476 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.69533357 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.63742520 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.60967766 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.56429879 |
| 27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.56190540 |
| 28 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.52966706 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49203855 |
| 30 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.48695384 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.45801702 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.42673932 |
| 33 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.41928667 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.41533549 |
| 35 | Melanogenesis_Homo sapiens_hsa04916 | 1.38377585 |
| 36 | Adherens junction_Homo sapiens_hsa04520 | 1.36423161 |
| 37 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.36049976 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.34124507 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28536761 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.25996774 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.23560082 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19675750 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.17543793 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17205147 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.14159776 |
| 46 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.11877440 |
| 47 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.10692660 |
| 48 | Glioma_Homo sapiens_hsa05214 | 1.10610939 |
| 49 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.10219017 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08280597 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 1.07363312 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 1.05567385 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.04970923 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03790238 |
| 55 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.03378449 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01858406 |
| 57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.01652543 |
| 58 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.00342301 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.98366534 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.97561516 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97453101 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.96598309 |
| 63 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.95828094 |
| 64 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.94434241 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94046534 |
| 66 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93701913 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93272361 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.91948551 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.91835471 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.91742088 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90866872 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89178620 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88126750 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87605858 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.87312320 |
| 76 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.86339151 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85631342 |
| 78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84854861 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84014125 |
| 80 | Tight junction_Homo sapiens_hsa04530 | 0.82909711 |
| 81 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82851059 |
| 82 | Morphine addiction_Homo sapiens_hsa05032 | 0.82138917 |
| 83 | Axon guidance_Homo sapiens_hsa04360 | 0.81651312 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80914837 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80455207 |
| 86 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80221845 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80105897 |
| 88 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.80088831 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79824584 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79700703 |
| 91 | Gap junction_Homo sapiens_hsa04540 | 0.78663892 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.77915872 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76834695 |
| 94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76000540 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75971695 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74417908 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74052933 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.73484398 |
| 99 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73300912 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.72142313 |
| 101 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72063243 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70593019 |
| 103 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70380075 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68543843 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68511594 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68329393 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67150175 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66109451 |
| 109 | Salivary secretion_Homo sapiens_hsa04970 | 0.65587100 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65442883 |
| 111 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65025945 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.63833184 |
| 113 | Renin secretion_Homo sapiens_hsa04924 | 0.63761943 |
| 114 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63756658 |
| 115 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63727811 |
| 116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63194959 |
| 117 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63177006 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61303309 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.60768998 |
| 120 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59512326 |
| 121 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.59255335 |
| 122 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58762423 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58320235 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56975017 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56037697 |
| 126 | Long-term depression_Homo sapiens_hsa04730 | 0.54373578 |
| 127 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.53059949 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52788876 |
| 129 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52475124 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.51344348 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50814314 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50429215 |
| 133 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48560012 |
| 134 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48383391 |
| 135 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47388367 |
| 136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46316848 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45617630 |
| 138 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45426768 |
| 139 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.45244864 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44230176 |
| 141 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.43571749 |
| 142 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43479812 |
| 143 | Carbon metabolism_Homo sapiens_hsa01200 | 0.42207834 |
| 144 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40353783 |
| 145 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38136190 |
| 146 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36797313 |
| 147 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34385188 |
| 148 | Pertussis_Homo sapiens_hsa05133 | 0.30912220 |
| 149 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26376853 |
| 150 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25191783 |
| 151 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.20183611 |
| 152 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18056355 |
| 153 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.16615316 |
| 154 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15394555 |
| 155 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.14154588 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.03621596 |
| 157 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03274253 |
| 158 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.01103483 |
| 159 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1852505 |
| 160 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.1695130 |
| 161 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1074292 |
| 162 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1033303 |
| 163 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0783615 |
| 164 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0510996 |
| 165 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0493694 |
| 166 | Mineral absorption_Homo sapiens_hsa04978 | -0.0119041 |

